Blueprint Medicines Corporation Earning Date (BPMC)

USA |NASDAQ |USD

BPMC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jul 27, 2022 Jun 2022 $-1.91 - $-1.86
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jul 27, 2022 Jun 2022 $43.45M - $27.30M

Blueprint Medicines Corporation's next earnings date is Wednesday, Jul 27, 2022 for the fiscal quarter ending Jun 2022.

BPMC Earnings Date & History Chart

BPMC Earnings & Revenue Forecast

BPMC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 14 $-1.91 $-2.32 $-1.56
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 14 $-7.60 $-9.02 $-6.65
Dec 2023 14 $-5.69 $-7.81 $-3.62

BPMC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 2 / 1 $-1.86 $-1.84 $-1.78
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 1 $-7.38 $-7.35 $-6.94
Dec 2023 1 / 1 $-5.52 $-5.44 $-4.30

BPMC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 13 $43.45M $27.70M $66.40M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 14 $190.44M $173.20M $199.52M
Dec 2023 14 $350.10M $252.50M $546.80M

BPMC Earnings Date & Revenue History

BPMC Earnings History

|
Show More
Show More

BPMC Revenue History

|
Show More
Show More

Blueprint Medicines Corporation Next Earnings Date & Report

BPMC Next Earnings Date & Report Preview: Jun 2022 (FQ)

BPMC's next earnings date is Wednesday, Jul 27, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Blueprint Medicines Corporation's next quarterly earnings is $-1.91, with a low EPS estimation of $-2.32, and a high estimation of $-1.56.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 1 downward. The EPS 1 month trend is $-1.86, the last 2 month trend is $-1.84, and the 3 month trend is $-1.78.

Based on analysts, the average revenue estimation is $43.45M, with a low revenue estimation of $27.70M, and a high estimation of $66.40M.

Blueprint Medicines Corporation Previous Earnings Dates & Reports

BPMC Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Blueprint Medicines Corporation's previous earnings date was May 3, 2022 for its fiscal quarter ended Mar 31, 2022.

BPMC Previous Earnings Date & Report Recap: Dec 2021 (FY)

Blueprint Medicines Corporation's previous annual earnings date was Feb 16, 2022 for its fiscal year ended Dec 31, 2021.

BPMC's earnings per share (EPS) was $-10.98, missing the consensus analysts forecast of $-6.93 by 58.44% , and lower than the previous year's EPS (Dec 2020) by -309.54%.

Revenues were $180.08M, better than the forecast of $176.49M by 2.03%, and down by -77.31% from previous year's revenue.

The company reported a net income of $-644.09M.

Blueprint Medicines Corporation reported a free cash flow of $-559.89M for its fiscal year, compared to $383.88M a year ago.

The company ended the fiscal year with $111.41M in total debt, an increase of 24.33% compared to the previous year.